Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMBD1P is a designated pseudogene presumed to be related to the family of somatomedin B domain-containing proteins. Pseudogenes are DNA sequences similar to known genes but are typically non-functional due to disrupted coding capacity and lack of expression. Protein-coding genes with somatomedin B domains (e.g., SBSPON, vitronectin) act as extracellular matrix components and may be involved in cell-substrate interactions[1][4][5]. However, SMBD1P itself is not known to encode a functional protein and is not recognized as a drug discovery target, receptor, enzyme, or biomarker. If you are seeking information on functional proteins in the somatomedin B domain family, focus on established genes such as SBSPON and VTN[4][5]. If a functional context for SMBD1P arises, it should be reviewed for accuracy and relevance, as current knowledge classifies it as a non-functional sequence.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatomedin B domain containing 1, pseudogene (SMBD1P).